Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...
Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
EMR-based nudge interventions can influence molecular genotyping ordering behavior to promote comprehensive molecular testing and delivery of guideline-concordant care in the 1L treatment setting in ...
This article is authored by Dr Kirti Chadha, chief scientific and innovation officer, Metropolis Healthcare Limited.
A panelist discusses how guidelines from organizations like the National Comprehensive Cancer Network (NCCN) can improve clinician awareness and adoption of molecular testing in community oncology ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...
Molecular You, a Vancouver, B.C., healthy longevity company, announced today that it has raised $5 million from investors. The company offers testing for a slate of 250 biomarkers that can provide ...
Management reiterated its plan to submit for FDA authorization of GraftAssureDx by year-end and is targeting a mid-2026 commercial launch, with Riggs stating, "we are still preparing for a mid-'26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results